B. Metzler seel. Sohn & Co’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
VCM
VPM
B. Metzler seel. Sohn & Co's ELV Position: Q1 2026 in Review
B. Metzler seel. Sohn & Co increased its Elevance Health (ELV) stake by 3.4% in Q1 2026, buying an estimated $252K and bringing the position to 23,525 shares worth $6.89M. The position accounts for 0.06% of the portfolio, ranked #169.
B. Metzler seel. Sohn & Co first reported a position in ELV in Q4 2020 and has held it in 22 quarters since. The position peaked at $21.4M in Q4 2020. 1,467 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- B. Metzler seel. Sohn & Co held 23,525 shares of Elevance Health worth $6.89M as of Q1 2026.
- B. Metzler seel. Sohn & Co bought 768 Elevance Health shares in Q1 2026, an estimated $252K.
- Elevance Health made up 0.06% of B. Metzler seel. Sohn & Co's portfolio in Q1 2026, its #169 holding.
- B. Metzler seel. Sohn & Co first reported a position in Elevance Health in Q4 2020 and has held it in 22 quarters since.
- B. Metzler seel. Sohn & Co's Elevance Health position peaked at $21.4M in Q4 2020.
- 1,467 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on B. Metzler seel. Sohn & Co's 13F filing for Q1 2026, filed 8 May 2026.